EUVIMEDEUVIMED entdecken
Crossref

Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer

Ryo Sugiura iD, Masaki Kuwatani iD, Kazumichi Kawakubo, Kazuma Kishi iD, Hiroki Yonemura, Shunichiro Nozawa, Masatsugu Ohara, Takehiro Noji iD, Satoshi Hirano, Naoya Sakamoto

Journal of Hepato-Biliary-Pancreatic Sciences · 2024

DOI: 10.1002/jhbp.12006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Ryo Sugiura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Sarcopenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endoscopic retrograde cholangiography (ERC)‐related procedures, usually performed before biliary tract cancer (BTC) surgery, are associated with increased risk for various complications, which can cause sarcopenia. No study has previously elucidated the relationship between preoperative ERC‐related procedures and sarcopenia/skeletal muscle mass loss.

Methods

Patients with BTC who underwent radical surgical resection following ERC‐related procedures were included. Skeletal muscle mass was evaluated using the psoas muscle mass index (PMI), which was determined using computed tomography images, and the change in PMI before the initial pre‐ERC and surgery (ΔPMI) was calculated. Risk factors for advanced skeletal muscle mass loss, defined as a large ΔPMI, were evaluated.

Results

The study cohort included 90 patients with a median age of 72 (interquartile range, 65–75) years. The median PMI pre‐ERC and surgery was 4.40 and 4.15 cm 2 /m 2 , respectively ( p < .01). The median ΔPMI was −6.2% (interquartile range, −10.9% to 0.5%). By multivariate analysis, post‐ERC pancreatitis and cholangitis before surgery were independent predictive factors for large PMI loss (odds ratio, 4.57 and 3.18, respectively; p = .03 and p = .02, respectively).

Conclusions

Skeletal muscle mass decreases preoperatively in most patients with BTC undergoing ERC. Post‐ERC pancreatitis and cholangitis before surgery were independent risk factors for large skeletal muscle mass loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract NeoplasmsSarcopeniaHumansMaleFemaleAgedRisk FactorsRetrospective StudiesTomography, X-Ray ComputedCholangiopancreatography, Endoscopic RetrogradePsoas MusclesMuscle, SkeletalMiddle AgedPreoperative PeriodPostoperative ComplicationsRisk Assessment

Stichwörter der Autor:innen

biliary tract cancerendoscopic retrograde cholangiographypsoas musclesarcopeniaskeletal muscle

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Department of Gastroenterological Surgery II, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

ORCID-Profile: Ryo Sugiura, Masaki Kuwatani, Kazuma Kishi, Takehiro Noji

Zitieren

APA

Sugiura, R., Kuwatani, M., Kawakubo, K., Kishi, K., Yonemura, H., Nozawa, S., Ohara, M., Noji, T., Hirano, S., & Sakamoto, N. (2024). Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12006

Vancouver

Sugiura R, Kuwatani M, Kawakubo K, Kishi K, Yonemura H, Nozawa S, et al. Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.12006

BibTeX
@article{Sugiura2024,
  author = {Sugiura, Ryo and Kuwatani, Masaki and Kawakubo, Kazumichi and Kishi, Kazuma and Yonemura, Hiroki and Nozawa, Shunichiro and Ohara, Masatsugu and Noji, Takehiro and Hirano, Satoshi and Sakamoto, Naoya},
  title = {Preoperative risk factors for skeletal muscle mass loss in patients with biliary tract cancer},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2024},
  doi = {10.1002/jhbp.12006}
}
Kostenlos starten →